Research & Development



  樊波苦笑道︰“怎麼可能,我得馬上去把它賣掉。”他回頭看了眼低矮閣樓里的床鋪,“老人等著看病買藥,小孩子等著上學,哪都需要用錢……”   黎斯一回頭,身後的人是童百泉。彩票app大全中彩在线   “我只是查一下,不是買。”手机彩票app大全   “嘖。”我大為遺憾。   “這個你不需要知道,先解開隱示局吧。”福小生帶著笑容說,“奇門遁甲、鬼神謎局,無論多麼神奇的局境都存在立、破兩點,立即死,破即生。若入局者沉溺于假象中,那麼你就是死相,反之,若你找到了破點,那麼就是生相,局境可破。只是有些可惜……好了,你該把答案說出來了。”彩票时时彩软件下载   羅大人的手突然松了下來,說道︰“原來還是位黌門。只是張先生阻我歸程,到底有何見教?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo